Possible involvement of the total amount of morphine infused in the development of acute morphine dependence in rats.
The severity of naloxone-precipitated withdrawal in rats infused intravenously with morphine at the rates of 2.5, 5 and 10 mg/kg/hr over various time periods was investigated. Plasma morphine concentration reached a constant and rate-dependent level at 1 hr after the start of morphine infusion, and this level was maintained until the termination of infusion. Naloxone (2.0 mg/kg, s.c.) was challenged 18 hr after infusion was stopped, and the withdrawal was evaluated by plasma corticosterone (PCS) increase, diarrhea and body weight loss. The incidence of naloxone-precipitated withdrawal signs was related to both the infusion rate and duration of morphine infusion. The duration of morphine infusion (ET50) needed to elicit naloxone-precipitated PCS increase and diarrhea in 50% of the rats was inversely related to the morphine infusion rates, but the total amount of infused morphine (EA50) that elicited naloxone-precipitated withdrawals in 50% of rats was the same at all infusion rates. These results suggest that the total amount of morphine infused may play an important role in the development of acute physical dependence on morphine rendered by continuous intravenous morphine infusion for 1-8 hr.
Kishioka
S
S
Department of Pharmacology, Wakayama Medical College, Japan.
Inoue
N
N
Nishida
S
S
Fukunaga
Y
Y
Yamamoto
H
H
D000208:Acute Disease; D000704:Analysis of Variance; D000818:Animals; D003345:Corticosterone / Q000097:blood; D003967:Diarrhea / Q000209:etiology; D007262:Infusions, Intravenous; D008297:Male; D009020:Morphine / Q000008:administration & dosage* / Q000097:blood; D009021:Morphine Dependence / Q000097:blood / Q000209:etiology*; D009270:Naloxone / Q000494:pharmacology; D009292:Narcotic Antagonists / Q000494:pharmacology; D051381:Rats; D017207:Rats, Sprague-Dawley; D013375:Substance Withdrawal Syndrome / Q000097:blood / Q000209:etiology; D013997:Time Factors; D015431:Weight Loss / Q000187:drug effects
D009292:Narcotic Antagonists; D009270:Naloxone; D009020:Morphine; D003345:Corticosterone